Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia.

@article{Collins2008ComparativeCO,
  title={Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia.},
  author={Curtis D. Collins and Jeffrey J Ellis and Daniel R Kaul},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  year={2008},
  volume={65 23},
  pages={
          2237-43
        }
}
PURPOSE A cost-effectiveness analysis was performed to investigate the financial impact of using posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia. METHODS A decision-analytic model was developed from a hospital perspective based on the use of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia (i.e., longer than 7-10 days). Data reported in a multicenter study, medication-cost information, and… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-2 OF 2 REFERENCES

Comparative cost - effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia

  • OA Cornely, J Maertens, DJ Winston

Similar Papers

Loading similar papers…